Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 6, 2007, Pages 925-929

  Wang, Fangyu ^a,b   Tahara, Tomomitsu ^a   Arisawa, Tomiyasu ^a,c   Shibata, Tomoyuki ^a   Nakamura, Masakatsu ^a   Fujita, Hiroshi ^a   Iwata, Masami ^a   Kamiya, Yoshio ^a   Nagasaka, Mitsuo ^a   Takahama, Kazuya ^a   Watanabe, Makoto ^a   Hirata, Ichiro ^a   Nakano, Hiroshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NANJING UNIVERSITY   (China)

^c NONE   (Japan)

Author keywords

CD14; Genetic polymorphism; Toll like receptor 2 (TLR2); Ulcerative colitis

Indexed keywords

CD14 ANTIGEN; STEROID; TOLL LIKE RECEPTOR 2;

ALLELE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HOSPITALIZATION; HUMAN; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK; ULCERATIVE COLITIS;

EID: 34250365834     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2007.04909.x     Document Type: Article

References (33)

1. Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand. J. Gastroenterol. 2001 36 : 2 15.
2. Karlinger K, Gyorke T, Mako E, Mester A, Tarjan Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur. J. Radiol. 2000 35 : 154 67.
3. Sakamoto N, Kono S, Wakai K et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm. Bowel Dis. 2005 11 : 154 63.
4. Podolsky DK. Inflammatory bowel disease. N. Engl. J. Med. 2002 347 : 417 29.
5. Newman B, Siminovitch KA. Recent advances in the genetics of inflammatory bowel disease. Curr. Opin. Gastroenterol. 2005 21 : 401 7.
6. Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003 124 : 521 36.
7. Franchimont D, Vermeire S, Housni HE et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004 53 : 987 92.
8. Langholz Munkholm Davidsen Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994 107 : 3 11.
9. Noguchi E, Nishimura F, Fukai H et al. An association study of asthma and total serum immunoglobin E level for Toll-like receptor polymorphisms in Japanese population. Clin. Exp. Allergy 2004 34 : 177 83.
10. Hubacek JA, Rothe G, Pit'ha J et al. C (-260) → T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 1999 99 : 3218 20.
11. Mahida YR, Rolfe VE. Host-bacterial interactions in inflammatory bowel disease. Clin. Sci. (Lond.) 2004 107 : 331 41.
12. Swidsinski A, Ladhoff A, Pernthaler A et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002 122 : 44 54.
13. Rath HC, Schultz M, Freitag R et al. Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect. Immun. 2001 69 : 2277 85.
14. Ruemmele FM, Beaulieu JF, Dionne S et al. Lipopolysaccharide modulation of normal enterocyte turnover by Toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha. Gut 2002 51 : 842 8.
15. Boone DL, Ma A. Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease. J. Clin. Invest. 2003 111 : 1284 6.
16. Pierik M, Joossens S, Van Steen K et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm. Bowel Dis. 2006 12 : 1 8.
17. Hugot JP, Thomas G. Genome-wide scanning in inflammatory bowel diseases. Dig. Dis. 1998 6 : 364 9.
18. Campieri M, Gionchetti P. Bacteria as the cause of ulcerative colitis. Gut 2001 48 : 132 5.
19. Canto E, Ricart E, Monfort D et al. TNF alpha production to TLR2 ligands in active IBD patients. Clin. Immunol. 2006 119 : 156 65.
20. Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered sensing or changes in mucosal integrity take 'toll'? World J. Gastroenterol. 2006 12 : 1829 41.
21. Klein W, Tromm A, Griga T et al. A polymorphism in the CD14 gene is associated with Crohn's disease. Scand. J. Gastroenterol. 2002 37 : 189 91.
22. Gazouli M, Mantzaris G, Kotsinas A et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J. Gastroenterol. 2005 11 : 681 5.
23. Obana N, Takahashi S, Kinouchi Y et al. Ulcerative colitis is associated with a promoter polymorphism of lipopolysaccharide receptor gene, CD14. Scand. J. Gastroenterol. 2002 37 : 699 704.
24. Guo QS, Xia B, Jiang Y et al. Polymorphisms of CD14 gene and TLR4 gene are not associated with ulcerative colitis in Chinese patients. Postgrad. Med. J. 2005 81 : 672.
25. Peters KE, O'Callaghan NJ, Cavanaugh JA. Lack of association of the CD14 promoter polymorphism -159C/T with Caucasian inflammatory bowel disease. Scand. J. Gastroenterol. 2005 40 : 194 7.
26. Goyert SM, Ferrero E, Rettig WJ, Yenamendra AK, Obata F, LeBeau MM. The CD14 monocyte differentiation antigen encoding growth factors and receptors. Science 1988 239 : 497 500.
27. Griga T, Wilkens C, Schmiegel W et al. Association between the promoter polymorphism T/C at position -159 of the CD14 gene and anti-inflammatory therapy in patients with inflammatory bowel disease. Eur. J. Med. Res. 2005 10 : 183 6.
28. Meijssen MA, Brandwein SL, Reinecker HC, Bhan AK, Podolsky DK. Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2 deficient mice. Am. J. Physiol. 1998 274 : G472 9.
29. de Buhr MF, Mahler M, Geffers R et al. CD14, GBP1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses. Physiol. Genomics 2006 25 : 426 34.
30. Cantor MJ, Nickerson P, Bernstein CN. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am. J. Gastroenterol. 2005 100 : 1134 42.
31. Spiik AK, Ridderstad A, Axelsson LG, Midtvedt T, Bjork L, Pettersson S. Abrogated lymphocyte infiltration and lowered CD14 in dextran sulfate induced colitis in mice treated with p65 antisense oligonucleotides. Int. J. Colorectal Dis. 2002 17 : 223 32.
32. Devitt A, Moffatt OD, Raykundailia C, Capra JD, Simmons DL, Gregory CD. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 1998 392 : 505 9.
33. Rioux JD, Silverberg MS, Daly MJ et al. Genome-wide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am. J. Hum. Genet. 2000 66 : 1863 70.